John McKolanis
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Cell Function and Interaction
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- CAR-T cell therapy research
Papers in
-
- Glycosylation and Glycoproteins Research 13
- RNA Interference and Gene Delivery 3
- Immunology 19
- Immunotherapy and Immune Responses 13
- Co-authors
- Olivera J. Finn (23 shared papers)Robert E. Schoen (8 shared papers)Daniel W. Cramer (4 shared papers)Ramesh K. Ramanathan (3 shared papers)A. James Moser (4 shared papers)Theresa L. Whiteside (4 shared papers)Andres Μ. Salazar (5 shared papers)Kazi Islam (1 shared paper)
- Journals
- Cancer Research (4 papers)Journal of Clinical Oncology (3 papers)Cancer Epidemiology Biomarkers & Prevention (3 papers)Clinical Trials (2 papers)Cancer Immunology Immunotherapy (2 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
John McKolanis
34 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 66
- Immunology 635
- Oncology 522
- Reproductive Medicine 60
- Radiology, Nuclear Medicine and Imaging 144
- Biotechnology 45
Countries citing papers authored by John McKolanis
This map shows the geographic impact of John McKolanis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John McKolanis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John McKolanis more than expected).
Fields of papers citing papers by John McKolanis
This network shows the impact of papers produced by John McKolanis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John McKolanis. The network helps show where John McKolanis may publish in the future.
Co-authors
The 25 scholars most cited alongside John McKolanis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 193 | |
| 2 | 2004 | 176 | |
| 3 | A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors. | 2008 | 161 |
| 4 | 2005 | 101 | |
| 5 | 2019 | 85 | |
| 6 | 2005 | 83 | |
| 7 | 2007 | 53 | |
| 8 | 2010 | 42 | |
| 9 | 2010 | 35 | |
| 10 | 1989 | 31 | |
| 11 | 2006 | 27 | |
| 12 | 1986 | 12 | |
| 13 | 1988 | 11 | |
| 14 | 2003 | 9 | |
| 15 | Pharmacokinetics of recombinant interleukin-2 in children with malignancies: a Pediatric Oncology Group study. | 1990 | 8 |
| 16 | 2004 | 7 | |
| 17 | 2019 | 6 | |
| 18 | 1994 | 6 | |
| 19 | 1989 | 5 | |
| 20 | 2000 | 4 |
About John McKolanis
John McKolanis is a scholar working on Molecular Biology, Immunology, Oncology, Radiology, Nuclear Medicine and Imaging and Epidemiology, having authored 34 papers that have together received 1.1k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (13 papers), Immunotherapy and Immune Responses (13 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Cancer Immunotherapy and Biomarkers (4 papers), RNA Interference and Gene Delivery (3 papers), Cancer Research and Treatments (3 papers), Hepatitis B Virus Studies (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). The work is most often cited by research in Immunology (635 citations), Oncology (522 citations), Reproductive Medicine (60 citations), Radiology, Nuclear Medicine and Imaging (144 citations) and Biotechnology (45 citations). John McKolanis has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Olivera J. Finn, Robert E. Schoen, Daniel W. Cramer, Ramesh K. Ramanathan, A. James Moser, Theresa L. Whiteside, Andres Μ. Salazar, Kazi Islam, Douglas M. Potter and Takashi Kimura. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Cancer Epidemiology Biomarkers & Prevention, Clinical Trials and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.